Breast calcifications

Breast calcifications are small deposits of calcium that form within breast tissue. They are extremely common, appearing on imaging in women of all ages, and become more prevalent with age. They are not the same as calcium found in the diet and are not caused by eating dairy products or taking calcium supplements.

Calcifications are classified by their appearance on imaging, which determines their clinical significance:

• Benign calcifications are the most common type. These are large, round, or scattered spots caused by normal aging, healed cysts, or harmless non-cancerous growths. They require no action.

• Probably benign calcifications are spots that look almost completely safe but need a quick follow-up scan in a few months just to prove they aren't changing.

• Suspicious calcifications are tiny, clustered, or branching spots that track along a fluid duct. These require a small tissue sample (biopsy) to investigate further.

• Highly suspicious calcifications have features strongly associated with ductal carcinoma in situ (DCIS) or invasive cancer and require urgent biopsy.

The morphology and distribution of calcifications on imaging is the primary basis for classification, and this assessment requires dedicated breast imaging with high-resolution mammography or specialised MRI sequences.

Symptoms of breast calcifications

Breast calcifications almost never cause symptoms. They are identified exclusively through imaging. Associated findings that may accompany suspicious calcifications include:

• A palpable lump in the breast if calcifications are associated with a mass

• Skin changes or nipple discharge if a significant underlying lesion is present

• In the majority of cases: no symptoms whatsoever

The absence of symptoms is precisely why imaging-based detection is so important. Ductal carcinoma in situ, the pre-invasive breast cancer most commonly associated with suspicious calcifications, is almost always asymptomatic. Identifying it through imaging before it progresses to invasive cancer is one of the most clinically impactful outcomes breast imaging can produce.

What causes breast calcifications?

Breast calcifications develop through a variety of benign and malignant processes. Contributing causes include:

• Normal aging and fluid debris: the most common cause; calcium naturally settles into everyday fluid secretions and cellular debris inside the breast ducts over time.

• Shrinking tumors and cysts: harmless, non-cancerous growths (fibroadenomas) and fluid-filled sacs (cysts) frequently leave behind prominent calcium spots as they heal or shrink.

• Past tissue injury: known as fat necrosis, calcium can form around areas of the breast that have healed from a past injury, surgery, or radiation therapy.

• Aging arteries: calcium can naturally build up in the walls of blood vessels inside the breast as you get older, which is completely harmless.

• Early or active cancer: fast-growing cancer cells (like DCIS) can produce calcium or leave behind debris that calcifies, creating distinct patterns that alert doctors to disease.

How are breast calcifications detected?

Breast calcifications are detected through dedicated breast imaging. Blood tests play a very limited role in the assessment of calcifications themselves but are relevant to overall breast and metabolic health.

Breast and thoracic MRI Elfcare’s full-body MRI naturally covers your chest and breast tissue. MRI is highly sensitive for detecting breast masses and soft tissue abnormalities and can identify calcification-associated lesions, though it is less sensitive than mammography for identifying microcalcifications specifically. If the MRI detects any unusual breast tissue, Elfcare quickly coordinates a follow-up mammogram or targeted breast ultrasound for a definitive look.

Blood tests cannot detect breast calcifications but provide relevant hormonal and metabolic context. Relevant markers in Elfcare's panel include:

• Estradiol and progesterone: assess hormonal balance relevant to breast tissue proliferation and fibrocystic change

• CRP: reflects systemic inflammation associated with breast cancer risk

• HbA1c and glucose: metabolic health relevant to breast cancer risk context

• Prolactin: elevated prolactin causes breast tissue changes and nipple discharge that can accompany calcification-associated lesions

Why early detection matters

Ductal carcinoma in situ, the pre-invasive breast cancer most commonly detected through calcifications on mammography, is one of the most treatable breast conditions when identified at this stage. Treatment at the DCIS stage, before invasion has occurred, carries an excellent prognosis with five-year survival approaching 99%. The same condition identified after progression to invasive cancer carries a substantially higher treatment burden and less favourable prognosis. Calcifications identified as probably benign allow for short-interval surveillance rather than immediate biopsy, monitoring for any change that would prompt tissue sampling. Early identification of suspicious calcifications, even in an entirely asymptomatic woman, initiates a pathway that, if DCIS or early invasive cancer is found, provides the most favourable treatment conditions available.

How Elfcare can help

Elfcare's full body MRI covers the thorax and breast tissue as standard, identifying breast abnormalities including masses, structural distortion, and lesions associated with calcifications. When a breast abnormality is identified on Elfcare's MRI, dedicated mammography and breast ultrasound are arranged as the appropriate next step for calcification characterisation, as these remain the gold standard tools for this purpose.

Our blood panel covers the hormonal and metabolic markers most relevant to breast health context, including oestradiol, vitamin D, and metabolic risk markers.

If our MRI or blood tests identify a breast finding requiring further assessment, we take care of further diagnostics or refer you to the appropriate specialist.